What Is Type 3 Diabetes? Insulin Resistance and Brain Health
Have you heard of type 3 diabetes?
Diabetes and Alzheimer’s disease are two conditions that impact millions of people worldwide, but some experts have coined the term type 3 diabetes to describe a potential connection between these two horsemen of death.
The proposed mechanism is brain insulin resistance. Research suggests that when the brain’s own insulin signaling system breaks down, neurons may struggle to use glucose for energy, synaptic communication can weaken, and the brain’s ability to clear harmful proteins like amyloid beta may be compromised. These are the very changes researchers associate with Alzheimer’s disease. While more research is needed, mapping this connection could open the door to earlier detection and better management of both conditions.
In this post, we’ll look at what type 3 diabetes is, how it might be connected to Alzheimer’s, and how we can best reduce our risk for both conditions.
Key takeaways:
- Type 3 diabetes is a research term, not an official diagnosis, for the idea that brain insulin resistance may drive Alzheimer’s
- When the brain’s insulin signaling breaks down, processes involved in neuronal survival, synaptic health, and cellular maintenance may be affected
- Symptoms like memory loss, brain fog, and impaired judgment may signal brain insulin resistance worth discussing with your clinician
- Lifestyle changes including diet, exercise, sleep, and stress management can reduce your risk for both conditions
What Is Type 3 Diabetes?
Type 3 diabetes is not an official medical diagnosis, but rather a term used by some researchers to describe the hypothesis that Alzheimer’s disease may be caused by insulin resistance and insulin-like growth factor (IGF) dysfunction in the brain.
The idea is that the brain, like the body, can develop insulin resistance, which could contribute to the development of Alzheimer’s disease.
Type 3 diabetes may also describe cases where people with type 2 diabetes develop cognitive decline, dementia, and potentially Alzheimer’s disease.
Although organizations like the American Diabetes Association (ADA) don’t recognize type 3 diabetes as an official disease, a growing number of researchers suspect that insulin resistance, glucose control, and other conditions associated with diabetes may help explain why some people develop Alzheimer’s.
Types of Diabetes
|
Type |
Primary Cause |
Key Feature |
Connection to Alzheimer’s |
|---|---|---|---|
|
Type 1 diabetes |
Pancreas produces little or no insulin |
Requires insulin therapy; often diagnosed in childhood |
No confirmed direct link |
|
Type 2 diabetes |
Muscle and liver become resistant to insulin |
Most common form; strongly tied to lifestyle and genetics |
Linked to cognitive decline via chronic high blood sugar and systemic insulin resistance |
|
Gestational diabetes |
Hormonal changes during pregnancy cause insulin resistance |
Typically resolves after birth |
No confirmed direct link |
|
Type 3c (T3cDM) |
Damage to the pancreas (pancreatitis, cancer, or surgery) |
Recognized clinical diagnosis; often misidentified as type 2 |
No direct link to Alzheimer’s |
|
Type 3 diabetes (proposed) |
Insulin resistance in the brain’s own signaling system |
Not an official diagnosis; a research hypothesis linking brain insulin dysfunction to Alzheimer’s |
Proposed as a key driver of Alzheimer’s disease pathology |
Research suggests there may be a possible connection between diabetes, in particular type 2 diabetes, and Alzheimer’s disease. While the exact mechanism remains unclear, some scientists believe that insulin resistance and impaired sugar metabolism in the brain could be key factors in the development of Alzheimer’s.
For people with diabetes, especially those with undiagnosed or untreated type 2 diabetes, high blood sugar can damage blood vessels, including those in the brain. This damage may lead to chronic inflammation and other changes that affect brain health, potentially driving the progression of Alzheimer’s.
That said, not all cases of Alzheimer’s show a direct link to insulin resistance, and scientists need more research to fully understand the connection.
Brain Insulin Resistance and Cognitive Decline
The brain has its own insulin signaling system, separate from the one that governs blood sugar in muscle and liver cells. Neurons don’t need insulin for basic glucose uptake, but insulin still sends important growth and survival signals within the brain. These signals help support connections between neurons (synaptogenesis), brain cell survival, and processes involved in the formation of new neurons (neurogenesis). When brain cells become resistant to insulin, these signals may weaken, potentially affecting brain health over time.
Researchers believe this disruption may impair memory formation and reduce mental sharpness over time. Some studies also suggest it could speed up the accumulation of amyloid plaques and tau tangles, two hallmark features of Alzheimer’s disease. This is why some scientists now view brain insulin resistance as more than a downstream consequence of metabolic disease, and as a potential driver of cognitive decline in its own right.
Causes and Risk Factors: Type 3 Diabetes and Insulin Resistance
Alzheimer’s can really be considered an umbrella term for a set of different conditions that may lead to brain degeneration. Some of these conditions include:
- Insulin resistance: When brain cells stop responding properly to insulin signals, processes involved in neuronal survival, synaptic health, and cellular maintenance may be affected
- High blood sugar levels: Chronic high blood sugar can cause damage to blood vessels and nerves, including those in the brain
- Genetics: The APOE4 gene variant is the strongest known genetic risk factor for late-onset Alzheimer’s and is also linked to impaired insulin signaling in the brain, meaning carriers may be at higher risk for both conditions. A broader family history of diabetes or Alzheimer’s can also raise your risk
- Age: Older adults are at higher risk for both diabetes and Alzheimer’s
- Excess fat: Being overweight or obese is a risk factor for both type 2 diabetes and Alzheimer’s
- Heart and metabolic diseases: Diabetes and cardiovascular disease are both risk factors for Alzheimer’s
Symptoms of Type 3 Diabetes
While type 3 diabetes isn’t an official diagnosis, symptoms of insulin resistance in the brain can be subtle and may include:
- Memory loss
- Difficulty concentrating
- Chronic brain fog
If you notice these symptoms, especially if you have a history of diabetes, it’s important to talk to your healthcare provider. Early intervention may help prevent further brain damage, improve quality of life, and support better health outcomes.
Diagnosis of Type 3 Diabetes
There’s no official test for type 3 diabetes since it’s not a recognized condition. However, clinicians can diagnose Alzheimer’s disease through various assessments, including:
- Cognitive tests to assess memory, spatial navigation, attention, and problem-solving skills
- Blood tests to check for diabetes by measuring insulin resistance and other conditions that may contribute to cognitive decline, including the presence of neuroinflammatory factors (GFAP) and toxic proteins like amyloid beta and tau
- Brain imaging such as an fMRI or PET scans to look for signs of Alzheimer’s disease like degeneration of brain regions and issues with blood flow in the brain
If you have type 2 diabetes and notice memory problems or a combination of any of the other symptoms listed above, it’s important to have a conversation with your healthcare provider before the symptoms worsen or develop into disease.
Treating Type 3 Diabetes and Brain Insulin Resistance
While there is currently no cure for Alzheimer’s, both lifestyle changes and treatments can help manage the symptoms of Alzheimer’s and diabetes. Here’s a breakdown of the options:
Medications for Alzheimer’s Disease and Diabetes
- Cholinesterase inhibitors, like Donepezil, may help improve memory, decision making, and emotional health in people with Alzheimer’s
- Glutamate regulators, like Memantine, may help balance brain chemicals involved in memory and learning
- Amyloid beta drugs, like Lecanemab, can target and help clear amyloid beta proteins, which may help improve memory and problem-solving,
- Trazodone, which is sometimes prescribed off label for dementia, may help slow the rate of cognitive decline
- Methylene Blue, studied for brain health and mitochondrial function, may inhibit tau protein aggregation and help slow age-related cognitive decline in preclinical models, and has also been studied for its potential to reduce amyloid buildup in the brain
- Metformin or Acarbose may help control blood sugar and improve insulin sensitivity, which are key metabolic health goals for people managing diabetes risk. Some research, including a 2024 meta-analysis, has noted a potential association between Metformin use and lower rates of cognitive impairment.
Lifestyle Changes
- Healthy diet: While there is no specific diet that can control Alzheimer’s symptoms, restricting your diet to healthy, low-fat options that limit refined carbs and added sugars can help improve glucose control and reduce your risk for diabetes
- Exercise: Increasing physical activity is a good strategy for reducing diabetes risk, and it may reduce dementia and Alzheimer’s risk as well
- Stress management: Stress can stimulate hyperglycemia (high blood sugar) and other diabetes conditions; studies have also noted that chronic stress and Alzheimer’s risk
- Healthy sleep is one of the best ways we can optimize our longevity and reduce our risk for age-related diseases like diabetes and Alzheimer’s
When to Start Optimizing Your Risk
Both diabetes and Alzheimer’s can start to develop years before the conditions manifest. The decisions we make today can impact our longevity decades into the future, for better or for worse. That means it’s never too late to start optimizing your risk for diabetes and Alzheimer’s.
If you’re concerned you may be at risk, but don’t know where to start, try a longevity consultation with an AgelessRx expert to assess your current risk and see where you can best focus your efforts. This way, you can see whether simple lifestyle changes are sufficient, or if it’s time to start select treatments to optimize your glucose.
For a deeper understanding of your risk, you can also try in-depth blood tests like the Core Longevity Panel. With clear insights into 11 key biomarkers, including critical heart and diabetes markers, the Core Longevity Panel can help you determine whether you’re at risk, and whether it’s time to start optimizing your health.
Regular check-ups with your clinician can help you stay on top of both conditions and catch any signs of cognitive decline early.
By staying informed and proactive, you can take control of your health and reduce your risk of developing diabetes and Alzheimer’s, which can help improve your quality of life and extend your healthy lifespan. It’s up to you to decide when you’re ready to take control.
Frequently Asked Questions
Type 3 diabetes is a research term, not an official medical diagnosis recognized by organizations like the American Diabetes Association. It describes a hypothesis that brain insulin resistance may drive Alzheimer’s disease pathology, and researchers use it to study the biological overlap between metabolic dysfunction and cognitive decline.
Type 2 diabetes involves insulin resistance in muscle and liver cells, and chronic high blood sugar from this condition can damage brain blood vessels and raise Alzheimer’s risk over time. Type 3 diabetes, by contrast, refers to insulin resistance within the brain’s own signaling system in particular, which may impair how neurons produce energy, maintain synaptic connections, and clear amyloid beta proteins regardless of systemic blood sugar levels.
Research suggests Metformin may help lower the risk of cognitive impairment and Alzheimer’s by improving insulin sensitivity and supporting metabolic health, and AgelessRx offers both Metformin and Acarbose for longevity and metabolic aging support. That said, these treatments require clinician evaluation to determine whether they are appropriate for your specific health profile.
Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.